These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26238927)

  • 21. Hepatocellular carcinoma in Danish patients: a single Copenhagen center experience.
    Stefansdottir J; Christensen E; Schiødt FV
    Scand J Gastroenterol; 2017; 52(6-7):768-772. PubMed ID: 28355956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved surveillance for hepatocellular carcinoma with a primary care-oriented clinical reminder.
    Beste LA; Ioannou GN; Yang Y; Chang MF; Ross D; Dominitz JA
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):172-9. PubMed ID: 24813175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers for hepatocellular carcinoma.
    Wu AH; Sell S
    Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of small focal liver lesions in a cirrhotic liver: discussion.
    Reynaert H; Van Vlierberghe H; De Beeck BO; Roskams T
    Acta Gastroenterol Belg; 2006; 69(2):236-7. PubMed ID: 16929623
    [No Abstract]   [Full Text] [Related]  

  • 25. The Effect of Hepatocellular Carcinoma Surveillance in an Urban Population With Liver Cirrhosis.
    Nusbaum JD; Smirniotopoulos J; Wright HC; Dash C; Parpia T; Shechtel J; Chang Y; Loffredo C; Shetty K
    J Clin Gastroenterol; 2015; 49(10):e91-5. PubMed ID: 25751372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synopsis: Diagnosis and treatment of hepatocellular carcinoma in patients with cirrhosis].
    Ganne-Carrié N; Mohand D; N'kontchou G; Grando-Lemaire V; Trinchet JC
    Gastroenterol Clin Biol; 2002 Jan; 26(1):73-7. PubMed ID: 11938045
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
    Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New challenges in clinical research on hepatocellular carcinoma.
    Díaz-González Á; Forner A; Rodríguez de Lope C; Varela M
    Rev Esp Enferm Dig; 2016 Aug; 108(8):485-93. PubMed ID: 26653993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary approach for HCC patients: hepatology for the oncologists.
    Barone C; Koeberle D; Metselaar H; Parisi G; Sansonno D; Spinzi G
    Ann Oncol; 2013 Apr; 24 Suppl 2():ii15-23. PubMed ID: 23715939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis.
    Schwartz ME; Sung M; Mor E; Fisher A; Popescu I; Fiel I; Sheiner P; Emre S; Guy S; Miller CM
    J Am Coll Surg; 1995 May; 180(5):596-603. PubMed ID: 7749537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance for hepatocellular carcinoma: how can we do better?
    Hassett M; Yopp AC; Singal AG
    Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma development in cirrhosis.
    Okuda H
    Best Pract Res Clin Gastroenterol; 2007; 21(1):161-73. PubMed ID: 17223503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCV-related liver cancer in people with haemophilia.
    Meijer K; Haagsma EB
    Haemophilia; 2012 Jan; 18(1):17-24. PubMed ID: 21651676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice.
    Bottelli R; Tibballs J; Hochhauser D; Watkinson A; Dick R; Burroughs AK
    Clin Radiol; 1998 Oct; 53(10):713-6. PubMed ID: 9817086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma.
    Singal AG; Volk ML; Rakoski MO; Fu S; Su GL; McCurdy H; Marrero JA
    J Clin Gastroenterol; 2011 Sep; 45(8):727-32. PubMed ID: 21602704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.